Status: Not yet recruiting
This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye
This is a single-center prospective open-label, clinical trial to explore proteomic expression of tear fluid biomarkers in patients with dry eye treated with Lifitegrast.
Participants needed: 36
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: Pittsburgh Research InstituteUpdated: Mar 24, 2026Locations: 1
Eligibility criteria
At least 18 years of age or older at time of screening [+8]
Have a known hypersensitivity or contraindication to the product or their compon... [+35]